Balangu syrup on Gastroesophageal Reflux
Phase 2
- Conditions
- Gastroesophageal reflux.Gastro-oesophageal reflux diseaseK21.0,K21.
- Registration Number
- IRCT2016120331205N1
- Lead Sponsor
- Shahed University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 84
Inclusion Criteria
Based on the clinical symptoms of reflux in patients with gastroesophageal reflux;Heartburn; Gastroesophageal reflux from the stomach into the esophagus and mouth; patients who are unresponsive to conventional therapies.
Exclusion criteria:There are warning signs such as weight loss, anemia, severe vomiting and consuming food that has not been endoscopy and mechanical causes of food stuck in it is not rejected; Peptic strictures; complications of reflux; Barrett's esophagus approved in previous endoscopy patients; esophagitis with non-reflux causes; Systemic diseases (liver disease, kidney disease, uncontrolled diabetes); pregnancy; Anti-reflux surgery; Anti-reflux drugs
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical symptoms of reflux (heartburn or Gastroesophageal reflux from the stomach into the esophagus and mouth). Timepoint: 4 weeks. Method of measurement: The questionnaire is based on studies conducted by Lai et al (2006).
- Secondary Outcome Measures
Name Time Method